COVID-19 vaccinations prevent infections among healthcare workers

Becoming infected with COVID-19 is unlikely once a person has been vaccinated, according to a study published in the New England Journal of Medicine.

Researchers examined more than 8,000 vaccinated adults employed at the University of Texas Southwestern Medical Center in Dallas. Only four of the group became infected with COVID-19.

The findings reveal good news for tamping down the spread of the COVID-19 pandemic as the nation’s vaccination program continues to roll out. However, other recent studies show challenges when it comes to getting the healthcare workforce vaccinated, with a significant portion of workers feeling skeptical about the effectiveness and safety of the vaccines.

“The effect of vaccination on the preservation of our workforce has been dramatic,” wrote first author William Daniel, MD, of the medical center, et al. “We observed a greater than 90% decrease in the number of employees who are either in isolation or quarantine.”

Similarly, another study on infection rates among vaccinated staffers at Los Angeles hospitals revealed just seven of nearly 15,000 contracted COVID-19. The study was also published in NEJM.

“In our cohort, the absolute risk of testing positive for SARS-CoV-2 after vaccination was 1.19% among health care workers at [University of California San Diego Health] and 0.97% among those at [David Geffen School of Medicine at University of California, Los Angeles],” wrote first author Jocelyn Keehner, MD, of UCSD, and colleagues.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.